PL348152A1 - Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus - Google Patents

Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus

Info

Publication number
PL348152A1
PL348152A1 PL99348152A PL34815299A PL348152A1 PL 348152 A1 PL348152 A1 PL 348152A1 PL 99348152 A PL99348152 A PL 99348152A PL 34815299 A PL34815299 A PL 34815299A PL 348152 A1 PL348152 A1 PL 348152A1
Authority
PL
Poland
Prior art keywords
benzoylguanidines
insulin
treatment
diabetes mellitus
dependent diabetes
Prior art date
Application number
PL99348152A
Inventor
Rolf Gericke
Manfred Baumgarth
Klaus Minck
Didier Mesangeau
Liliane Doare
Micheline Kergoat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL348152A1 publication Critical patent/PL348152A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL99348152A 1998-11-26 1999-11-16 Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus PL348152A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98122419 1998-11-26

Publications (1)

Publication Number Publication Date
PL348152A1 true PL348152A1 (en) 2002-05-06

Family

ID=8233036

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99348152A PL348152A1 (en) 1998-11-26 1999-11-16 Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus

Country Status (14)

Country Link
EP (1) EP1131064A2 (en)
JP (1) JP2002530325A (en)
KR (1) KR20010080597A (en)
CN (1) CN1328452A (en)
AR (1) AR023064A1 (en)
AU (1) AU1553500A (en)
BR (1) BR9915667A (en)
CA (1) CA2352154A1 (en)
CZ (1) CZ20011785A3 (en)
HU (1) HUP0104418A2 (en)
ID (1) ID29523A (en)
NO (1) NO20012563D0 (en)
PL (1) PL348152A1 (en)
WO (1) WO2000030624A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA008769B1 (en) * 2002-06-05 2007-08-31 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Therapeutic drug for diabetes
US7381841B2 (en) 2003-08-22 2008-06-03 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
DE102004054847A1 (en) * 2004-11-13 2006-05-24 Sanofi-Aventis Deutschland Gmbh Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430916A1 (en) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl benzoylguanidine derivatives
DE4430861A1 (en) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidines
DE4437874A1 (en) * 1994-10-22 1996-04-25 Merck Patent Gmbh Alkyl 5-methylsulfonylbenzoylguanidine derivatives
DE19502644A1 (en) * 1995-01-28 1996-08-01 Merck Patent Gmbh 4-amino-benzoylguanidine derivatives
DE19502895A1 (en) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-mercapto-benzoylguanidine derivatives
DE19517848A1 (en) * 1995-05-16 1996-11-21 Merck Patent Gmbh Fluorine-containing benzoylguanidines
DE19531138A1 (en) * 1995-08-24 1997-02-27 Merck Patent Gmbh Alkenyl benzoylguanidine derivatives

Also Published As

Publication number Publication date
CN1328452A (en) 2001-12-26
BR9915667A (en) 2001-08-14
HUP0104418A2 (en) 2002-04-29
NO20012563L (en) 2001-05-25
ID29523A (en) 2001-09-06
JP2002530325A (en) 2002-09-17
AR023064A1 (en) 2002-09-04
EP1131064A2 (en) 2001-09-12
KR20010080597A (en) 2001-08-22
WO2000030624A3 (en) 2000-10-05
WO2000030624A2 (en) 2000-06-02
NO20012563D0 (en) 2001-05-25
CA2352154A1 (en) 2000-06-02
CZ20011785A3 (en) 2001-10-17
AU1553500A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
HK1045111A1 (en) (3-Trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin reisistance and type 2 diabetes
AU6865298A (en) The use of cryoprotective agent compounds during cryosurgery
IL130027A (en) Rosiglitazone - glyburide synergistic combinations for treatment of diabetes
AU6257599A (en) Non-invasive blood component analyzer
AU6726496A (en) Two-pulse, lateral tissue illuminator
EP1115422A4 (en) Use of non-peptidyl compounds for the treatment of insulin related ailments
AU4714393A (en) Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity
AU1450900A (en) Methods of treatment of type 2 diabetes
ZA9510223B (en) Fungicidal compounds
ZA953336B (en) Substituted sulfonamides as selective B3 agonists for the treatment of diabetes and obesity
HUP0003428A3 (en) Use of leptin antagonists for the treatment of diabetes
EP0612513A3 (en) External skin treatment composition.
AU7411398A (en) Improved methods for the diagnosis and treatment of insulin depdende nt diabete s mellitus
AU1405595A (en) Use of thalidomide for the treatment of non-insulin dependent diabetes mellitus
EP0999848A4 (en) Chimeric proteins for the treatment of diabetes
PL348152A1 (en) Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus
IL132032A0 (en) Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus
AU3344499A (en) Hypoglycemic agents
AU6258894A (en) Chimeric gene using the gene or cdna of insuline, specially for the gene therapy of diabetes
AU3117497A (en) Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
GB9919811D0 (en) Herbal preparation for the treatment of diabetes mellitus
GB9417620D0 (en) Water soluble biocide for medical instruments with wide spectrum activity
GB9808254D0 (en) Flexible endoscope cover
HRP980066B1 (en) Sulfonamide substituted compounds, processes for their preparation, their use as medicins or diagnostic agents as well as the medicine containing them
AU6256599A (en) Flexible disposable container